Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-023-02199-w, published online 01 March 2023
The original version contained a typo in the text: “Interim analysis of a Phase II trial (NCT03947385) exploring darovasertib and c-MET inhibitor crizotinib in metastatic uveal melanoma has shown an impressive ORR 31% in the first line in 35 evaluable patients with PFS not reached but already >5 months” should be changed to “ORR 31% in the any line in 35 evaluable patients”. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodrigues, A., Cosman, R. & Joshua, A.M. Correction To: LXS196 for Metastatic Uveal Melanoma - finally some progress. Br J Cancer 128, 1976 (2023). https://doi.org/10.1038/s41416-023-02231-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-023-02231-z
